Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 18.5 Cr.
- Current Price ₹ 5.77
- High / Low ₹ 29.0 / 3.78
- Stock P/E 2.23
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE 24.5 %
- ROE 29.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.37 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -14.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | 39.81 | |
| 0.57 | 0.61 | 0.53 | 8.93 | 31.54 | |
| Operating Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 |
| OPM % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% |
| 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | |
| EPS in Rs | 0.16 | 2.58 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 321% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1490% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 31% |
| 3 Years: | 35% |
| 1 Year: | -66% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 |
| Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 |
| 3.42 | 3.42 | 3.42 | 10.91 | 0.02 | |
| 0.23 | 0.25 | 0.27 | 0.02 | 0.02 | |
| Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 |
| 0.52 | 0.49 | 0.45 | 0.00 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 |
| 3.97 | 4.57 | 4.51 | 16.89 | 50.61 | |
| Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -13.46 | -25.48 | ||||
| 0.00 | -0.01 | ||||
| 12.58 | 25.46 | ||||
| Net Cash Flow | -0.88 | -0.03 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 2,286.62 | 1,246.51 | 1,476.22 | 132.87 | 107.09 |
| Inventory Days | 16.95 | 50.98 | |||
| Days Payable | 0.00 | 0.00 | |||
| Cash Conversion Cycle | 2,286.62 | 1,246.51 | 1,476.22 | 149.81 | 158.07 |
| Working Capital Days | 4,004.26 | 2,975.09 | 3,422.89 | 152.18 | 177.41 |
| ROCE % | -1.40% | -1.71% | 24.51% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Newspaper Publication for Audited Standalone and consolidated financial result for the year ended 2025
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Secretarial Compliance Report for FY ended 31 Mar 2025 filed by Shrydus Industries Limited.
-
Audited Standalone And Consolidated Financial Result For The Year Ended March 2025
30 May - Audited Q4 and FY25 financial results approved; secretarial auditor appointed for 5 years.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2025 For Approve The Audited Standalone And Consolidated Financial Result For Year Ended March 2025
30 May - Shrydus Industries approved audited FY25 standalone and consolidated results; appointed secretarial auditor for 5 years.
-
Board Meeting Intimation for Board Meeting Is Schedule On 30Th May, 2025 For Approve The Audited Standalone And Consolidated Finacial Result For The Financial Year March 31, 2025
23 May - Board meeting on 30 May 2025 to approve audited financial results for FY 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector